Dr. Brian Doherty

Company: Lipoid

Job title: Senior Manager - Business Development


Phospholipids in Vaccines 3:00 pm

The amphiphilic nature and safety profile of phospholipids make them ideal excipients for LNP formulations The lipid composition of LNPs and their impact on the delivery of mRNA Helper lipid selection can modulate the properties of LNP delivery and stability DSPC with its high phase transition temperature provides excellent colloidal stability to LNPs DOPE can…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.